Vor Biopharma Inc.
- Stock
- Ticker VOR
- Nasdaq
Performance, volatility and drawdowns of Vor Biopharma Inc. since 02/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $610. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −99.7% in 05/2025, measured from the peak in 02/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -31 | -33 | -274 | -28 | -36 | -35 | -48 | -58 |
| EBITDA | -30 | -32 | -272 | -26 | -36 | -35 | -48 | -58 |
| Net income | -31 | -32 | -1,574 | -813 | 1,723 | -220 | -63 | -87 |
| Earnings per share | -8.78 | -5.21 | -251.24 | -121.63 | 307.61 | -5.11 | -1.16 | -1.45 |
| Balance sheet | ||||||||
| Total assets | 143 | 109 | 205 | 176 | 464 | 507 | 481 | 496 |
| Liabilities | 46 | 43 | 1,711 | 2,402 | 628 | 657 | 681 | 633 |
| Equity | 97 | 66 | -1,506 | -2,225 | -164 | -150 | -200 | -137 |
| Cash | 82 | 50 | 191 | 160 | 396 | 170 | 108 | 79 |
| Cash flow | ||||||||
| Operating cash flow | -24 | -31 | -35 | -54 | -23 | -38 | -25 | -33 |
| Capital expenditure | -0.1 | -0.2 | -0.2 | -0.2 | -0.3 | 0.0 | -0.1 | 0.0 |
| Free cash flow | -24 | -31 | -35 | -54 | -23 | -38 | -25 | -33 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at −41.1%, weakest 2023 at −66.2%. 0 of 4 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 30 Oct 2026 | −$1.45 |
| 11 Aug 2026 | −$1.16 |
| 13 May 2026 | −$5.11 |
| 30 Mar 2026 | $307.61 |
| 13 Nov 2025 | −$121.63 |
| 12 Aug 2025 | −$251.24 |
| 14 May 2025 | −$5.21 |
| 20 Mar 2025 | −$8.78 |
| 7 Nov 2024 | −$8.05 |
| 8 Aug 2024 | −$0.41 |
| 9 May 2024 | −$0.45 |
| 20 Mar 2024 | −$0.38 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.1bn
- Market cap in trading currency
- $1.18bn
- Enterprise value
- $697m
- P/E
- 0.1
- P/S
- –
- P/B
- –
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- 1,562.7%
- FCF yield
- -10.2%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$177m
- Net income
- $1.35bn
- Earnings per share
- $299.89
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- –
- Return on assets
- 272.8%
Balance sheet and cash flow
- Cash
- $482m
- Cash per share
- $7.84
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 13.50
- Book value per share
- −$2.23
- Operating cash flow
- −$119m
- Free cash flow
- −$120m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 61.4m
- Volume
- 1.55m
- Avg. volume 3 months
- 937,917
- Relative volume
- 1.7
Price and technicals
- Price
- $19.19
- 1 day
- +3.6%
- 52-week high
- $25.10
- 52-week low
- $6.86
- Distance to 52-week high
- −23.5%
- Distance to 52-week low
- +179.7%
- Distance to 50-day line
- −1.5%
- Distance to 200-day line
- +8.5%
- RSI (14)
- 49
- Volatility 1M
- 63.3%
Performance
- 1 week
- −1.2%
- 1 month
- +1.3%
- 3 months
- −15.5%
- 6 months
- +33.9%
- YTD
- +46.7%
- 1 year
- +145.4%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has VOR performed since 02/2021?
$10,000 grew to $256 by 20 Nov 2026, which is −46.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is VOR?
Volatility was 309.0% per year, measured on monthly returns. The largest decline from a peak was −99.7%, with the low in 05/2025.
How does VOR compare with a broad equity ETF?
Over the same period Global equities (VT) returned +8.9% per year at 14.7% volatility, VOR returned −46.9% at 309.0%. The correlation of monthly returns was 0.08; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.